The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors.

Cancers (Basel) · 2025 · PMC11853050 · PMID 40002286

Europe PMC DOI

hedged sentence

0.0780

closest p · 1.6× alpha

0.0780

boldest claim

The sentences

did not reach statistical significancep = 0.078so close (0.05 < p ≤ 0.1)

While the count of hormone-sensitive patients in the PgR-low group was numerically lower than that in the PgR-high group, the difference did not reach statistical significance (67% vs. 75.8%; p = 0.078).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.